Coagulopathy and COVID-19

Yazici O., Bozkus F., Demirci N., Gulhan P. Y., Coskun F.

EURASIAN JOURNAL OF PULMONOLOGY, cilt.22, sa.4, ss.67-69, 2020 (ESCI) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 22 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4103/ejop.ejop_49_20
  • Dergi Adı: EURASIAN JOURNAL OF PULMONOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.67-69
  • Anahtar Kelimeler: COVID-19, coagulopathy, disseminated intravascular coagulation, SEPSIS
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19) is a potentially fatal disease as a global public health issue. Several mechanisms may be involved in mortality. One of these is coagulopathy and disseminated intravascular coagulation caused by SARS-CoV-2. When patients have coagulation disorders, treatment becomes more challenging and mortality rate increases accordingly. The aim of this article is to review the potential mechanisms of coagulopathy in COVID-19 in light of literature data.